Tin tức & Cập nhật
Xem bài viết Tiêu hóa
Xem

STRIDE regimen benefit in unresectable HCC consistent across baseline liver function
The overall survival (OS) benefit observed with the STRIDE regimen compared with sorafenib in patients with unresectable hepatocellular carcinoma (HCC) is consistent regardless of baseline liver function, according to exploratory analysis of data from the phase III HIMALAYA trial presented at ESMO GI 2022.

Nine metabolic biomarkers can detect gastric cancer
Gastric cancer (GC) patients show an altered metabolic profile as compared with healthy individuals, a recent China study has found. A biomarker panel monitoring for nine metabolites can facilitate timely detection of GC.

Incidence of peptic ulcer disease decreasing globally
Peptic ulcer disease (PUD) is still a major cause of hospitalization across the globe, but PUD-related hospitalizations and mortality have been on the decline in many countries belonging to the Organisation for Economic Co-operation and Development (OECD) across Asia, Europe, Oceania, North America, and Latin America, reports a study.





